Travere Therapeutics (TVTX) market cap

Market cap today
$4.91B

Travere Therapeutics (TVTX) has a market cap of $4.91B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.41B. That is 148.0% higher than the $1.37B of fiscal 2024. Today's figure is 43.9% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$4.91B
Market cap, fiscal 2025
$3.41B
Change on fiscal 2024
+148.0%
Growth, 5 years
+21.3% a year
Growth, 10 years
+16.7% a year
Highest on record
$3.41Bfiscal 2025
Lowest on record
$99.44Mfiscal 2013
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Travere Therapeutics market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 21.3% a year; over ten years the rate was 16.7% a year. Across the 13 fiscal year-ends on record (2013–2025), the highest was $3.41B in fiscal 2025 and the lowest $99.44M in fiscal 2013.

History · 13 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Travere Therapeutics market cap, year by year

Travere Therapeutics (TVTX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$4.91B—$51.10—
2025$3.41B 148.0% up$38.2189.21M
2024$1.37B 105.8% up$17.4278.89M
2023$667.66M 50.2% down$8.9974.27M
2022$1.34B 27.8% down$21.0363.76M
2021$1.86B 43.3% up$31.0459.83M
2020$1.30B 115.5% up$27.2547.54M
2019$601.23M 34.3% down$14.2042.34M
2018$915.00M 12.0% up$22.6340.43M
2017$816.88M 12.7% up$21.0738.77M
2016$724.79M 0.0% down$18.9338.29M
2015$724.95M 136.4% up$19.2937.58M
2014$306.70M 208.4% up$12.2425.06M
2013$99.44M—$7.0014.21M
2012——$3.35—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Travere Therapeutics and comparable companies
CompanyMarket cap
MiniMed Group MMED$5.00B
Adaptive Biotechnologies ADPT$4.61B
Heartflow HTFL$4.14B
CRISPR Therapeutics CRSP$3.89B
Travere Therapeutics TVTX$4.91B
Option Care Health OPCH$4.74B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on TVTX

Travere Therapeutics, figure by figure

Travere Therapeutics (TVTX) overview: price, valuation and scorecardAll health care companies by market value

Travere Therapeutics market cap: questions and answers

What is Travere Therapeutics's market cap?

Travere Therapeutics (TVTX) has a market cap of $4.91B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.41B. That is 148.0% higher than the $1.37B of fiscal 2024.

What is the growth rate of Travere Therapeutics's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 21.3% a year; over ten years the rate was 16.7% a year.

What are the highest and lowest market cap figures on record for Travere Therapeutics?

Across the 13 fiscal year-ends on record (2013–2025), the highest was $3.41B in fiscal 2025 and the lowest $99.44M in fiscal 2013.

How is Travere Therapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Travere Therapeutics it is on record here for 13 fiscal years, 2013 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Travere Therapeutics (TVTX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/TVTX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.